Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: The effect of NOD2/CARD15 mutations in a Tunisian population.
Bronchiolitis Obliterans
/ diagnosis
Case-Control Studies
Disease Susceptibility
Female
Gene Frequency
Genotype
Hematopoietic Stem Cell Transplantation
/ adverse effects
Humans
Incidence
Male
Mutation
Nod2 Signaling Adaptor Protein
/ genetics
Polymorphism, Single Nucleotide
Respiratory Function Tests
Risk Factors
Transplantation, Homologous
Tunisia
Journal
Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
17
09
2018
revised:
08
12
2018
accepted:
11
12
2018
pubmed:
16
12
2018
medline:
15
11
2019
entrez:
16
12
2018
Statut:
ppublish
Résumé
Bronchiolitis obliterans (BO) is a serious lung complication that can develop after allogenic stem cell transplantation. It has been suggested that single nucleotide polymorphisms (SNPs) that affect the NOD2/CARD15 gene impair its function and result in an uncontrolled innate immune response in the recipient, thereby leading to BO. One hundred eighty-one donor-recipient pairs were analyzed for the association between NOD2 gene variants (SNP8 [Arg702Trp], SNP12 [Gly908Arg], and SNP13 [Leu1007fsinsC]) and the occurrence of BO. Ten patients (2.8%) developed this complication. The incidence of BO increases in recipient variant patient group from 4.7% to 23% in donor Wild-type group in SNP8 (p < 0.001). The incidence rose to 19% when the recipient carried the SNP12 variant (p < 0.001) in the Tunisian population. Analyses demonstrated that recipient NOD2CARD15 variants (SNP8 and SNP12) present a greater risk in developing BO than recipients without mutation. Our study demonstrated that NOD2/CARD15 typing may be useful in identifying patients at high risk for BO.
Identifiants
pubmed: 30552907
pii: S0198-8859(18)30841-3
doi: 10.1016/j.humimm.2018.12.005
pii:
doi:
Substances chimiques
NOD2 protein, human
0
Nod2 Signaling Adaptor Protein
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
163-168Informations de copyright
Copyright © 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.